Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53.

Arya, A K

Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53. [electronic resource] - British journal of cancer Jul 2010 - 186-95 p. digital

Publication Type: Journal Article

1532-1827

10.1038/sj.bjc.6605739 doi


Animals
Carcinoma, Squamous Cell--drug therapy
Cell Proliferation--drug effects
Cell Survival--drug effects
Cellular Senescence--drug effects
Genes, p53
Imidazoles--analysis
Laryngeal Neoplasms--drug therapy
Piperazines--analysis
Proto-Oncogene Proteins c-mdm2--antagonists & inhibitors
Radiation Tolerance--drug effects
Radiation-Sensitizing Agents--pharmacology